5 Stocks to Buy According to Peter Simmie’s Bristol Gate Capital

2. Thermo Fisher Scientific Inc. (NYSE:TMO)

Bristol Gate Capital Stake Value: $118,003,000
Percentage Bristol Gate Capital’s 13F Portfolio: 5.3%
Number of Hedge Fund Holders: 95

Thermo Fisher Scientific Inc. (NYSE:TMO) is a company that makes analytical instruments, equipment, software, and diagnostics for research, reagents and consumables, analysis, and discovery. Among the hedge funds tracked by Insider Monkey in Q4 2021, 95 funds were bullish on Thermo Fisher Scientific Inc. (NYSE:TMO), up from 94 funds in the preceding quarter.

On February 3, Wells Fargo analyst Dan Leonard reduced his price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $605 from $700 and kept an Equal Weight rating on the shares after quarterly results. Post-pandemic expectations, according to the expert, were unrealistically high.

Ken Fisher’s Fisher Asset Management held the biggest stake in Thermo Fisher Scientific Inc. (NYSE:TMO) in the fourth quarter of 2021, with 2.15 million shares worth $1.44 billion. Thermo Fisher Scientific Inc. (NYSE:TMO) accounts for about 5.3% of Bristol Gate Capital’s portfolio, as the hedge fund owns a $118 million stake in the company.

In its third quarter 2021 investor letter, Baron Funds mentioned Thermo Fisher Scientific Inc. (NYSE:TMO). Here is what the fund said:

“We added to our position in Thermo Fisher Scientific Inc., a leading provider of life sciences tools & services. Thermo Fisher is a well-managed business with secular tailwinds in attractive life sciences end markets. At the company’s annual investor day, management provided long-term financial targets consisting of 7% to 9% core organic revenue growth and mid-teens annual earnings and free cash flow growth. We continue to like Thermo Fisher as a long-term earnings compounder.”